. "Acute oral LD50 in 1000 mg/kg in mouse and 5000 mg/kg in rat."@en . . "Tyloxapol, when injected IP, blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. It has also been shown to be inhibitor of lipoprotein lipase, thus preventing triglyceride uptake. "@en . . " "@en . "25301-02-4"@en . "investigational"@en . . . . "# Bhatia AJ, Wade GN: Effects of pregnancy and ovarian steroids on fatty acid synthesis and uptake in Syrian hamsters. Am J Physiol. 1991 Jan;260(1 Pt 2):R153-8. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1992816"@en . "Humans and other mammals"@en . . "approved"@en . . "Used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications."@en . . . . . . "Tyloxapol is a non-ionic detergent often used as a surfactant. "@en . "Tyloxapol"@en . . .